A $10,000 Investment in Aphria (TSX:APHA) 4 Years Ago Is Worth a Fortune Today

Canadian cannabis producer Aphria (TSX:APHA)(NYSE:APHA) is back in the limelight. But this time, there is no negative publicity. Investors are elated to receive good news from the cannabis sector for a change. Investors who have stuck with the weed stock for the last four years could be harvesting a huge bounty today. The third-largest licensed cannabis producer announced positive earnings…

Read More

Should HEXO (TSX:HEXO) Stock Be a Top Pick Today?

HEXO (TSX:HEXO)(NYSE:HEXO) has given back most of its 2019 gains, and investors are wondering if the Canadian marijuana producer is a buy right now or should be avoided. Let’s take a look at the current situation to see if HEXO deserves to be in your portfolio. Market conditions Every new industry goes through volatility, and the rapid rise of the…

Read More

Should You Buy Cronos Group (TSX:CRON) on the Dip?

Cronos Group (TSX:CRON)(NASDAQ:CRON) is perhaps the most expensive cannabis stock as far as forward valuations are concerned. It’s also been the target of several analyst downgrades thanks to its premium multiple to its peers. With the entire sector experiencing a pullback during the past few weeks, here are two reasons why you should buy Cronos, and one reason why you…

Read More

Should You Bet on a Rebound in Weed Stocks?

Cannabis stocks are down significantly in the past two months and investors are trying to decide if the pullback presents a good opportunity to buy marijuana stocks in their portfolios. Growing pains Every new industry goes through periods of volatility, and the rapid rise of the cannabis sector from penny-stock outliers to mainstream media darlings with billion dollar market caps…

Read More